Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Setting The Stage For Neurocrine's Pending PDUFA Date, Barclays Remains Positive

By: via Benzinga
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) is on the verge of becoming a commercial biotech company, as its PDUFA date for Ingrezza in ...
Related Stocks:
Neurocrine Bioscienc
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.